KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development…

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT)  …

Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will…

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne…

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins…

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives,…

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded…

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a…

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together…

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A….

By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019,…

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The…

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma…

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture…

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative…

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster…

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of…

The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease  …

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases,…

This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The…

On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great…

This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the…

HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100…

Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited…

BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do…

The VersiTMPD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance

Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit   In any factory,…

The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14…

Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France.   Last year,…

A grant to fund the Rapid-C Real-Time Microbial Detector    Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF…

Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective…

Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her…

The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain   Neurosoft Bioelectronics, an early-stage…

18 new foreign life sciences companies settled in our region in 2021   Last year, according to GGBa’s annual report,…

13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program.   Tech4Eva is an…

The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell…

Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech…

A new device for brain research at the Campus Biotech   Next summer, the Human Neuroscience Platform (HNP) at Campus…

Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals   Completely paralyzed…

🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie…

The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx…

The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology   Nagi Bioscience has been bestowed the prestigious and highly…

The Ukraine Embassy launches an appeal for donations   Collection points in Switzerland The war in Ukraine has thrown millions…

The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one.   The device, called…

A mutation in the Fer2 gene causes motor deficiencies in flies   The laboratory of Emi Nagoshi, Professor in the…

A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first…

The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that…

A coworking space designed for scientists   Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in…

A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack   In about 2/3…

A protein that boosts the immune system can cure 90% of cancer in mice   Immunotherapy, which aims to boost…

The pharmaceutical group GlaxoSmithKline creates Haleon, a new company from the separation of its consumer healthcare business. This entity will…

Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the…

🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.

After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital…

New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new…

The ‘Fitbit of Plants’ uses AI sensors to monitor crops   The startup Vivent provides growers with a technology to…

🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of…

Voters have rejected a complete ban on experiments on living creatures in Switzerland.   The idea of putting an end…

Adaptyv Biosystems is to create the world’s largest protein design database   The company, based in Biopôle in Epalinges, is…

A new medical Innovation Hub will open in 2024   “This is not a real estate project to house the…

The Lausanne-based company will open a branch office in San Diego to continue its growth   HAYA closes US$ 5…

  🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the…

The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme.   The…

A new implant enables patients with a complete spinal cord injury to stand, walk and even swim    Michel Roccati,…

La Source opens an innovation platform dedicated to care and health in Vaud (Switzerland).   The H4 “Hands-on Human Health…

A partnership of medtech pioneers and company-builders   Distalmotion, based in Lausanne (Switzerland), Revival Healthcare Capital and 415 CAPITAL announced…

The pharmaceutical group Takeda wishes to increase the production capacity of its site in Neuchâtel (Switzerland) and will build a…

Development & commercialisation of ZYNLONTA in Japan   ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those…

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission,…

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for…

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841…

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs…

GeNeuro received CHF 6.7 million in funding for the development of temelimab against Long-COVID   GeNeuro, a biopharmaceutical company developing…

Merck invests into Cadribine to try to cure rare neuroinflammatory diseases   Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing…

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the…

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private…

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of…

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated…

Underlines the ambition of the HEIG-VD to pursue its development in management applied to the health sector, both in the field of education and research

Deep Bio and HealthCare Konnect (HCK) partner to improve cancer diagnosis in Switzerland and North Africa   On 18 October…

Investing, innovating and hiring in Switzerland to prevent infection worldwide   We are pleased to share with you our new…

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Switzerland establishes a national infrastructure to track COVID-19 and its variants Discover the role of the Swiss Pathogen Surveillance Platform…

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

A necessity for scientific progress   Despite the many advancements in developing innovative alternative methods, animal testing still plays an…

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

The first two beneficiaries of the FIF   The foundation supporting technological entrepreneurship in the canton of Geneva, FONGIT, announces…

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

Welcome to new activity report of the SIB Swiss Institute of Bioinformatics, the nationwide organisation dedicated to biological and biomedical…

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

In honor of Women’s International Day, EPFL Innovation Park is announcing the launch of Tech4Eva, the first Femtech accelerator in Switzerland,…

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…

Netsensing Technology secures a seed financing round to accelerate Home Sleep Apnea Test device development   Netsensing Technology Sàrl has…

A new scientific communication platform   A new scientific communication platform entitled “Connect People with Science” is being launched. Its…

Geneva: 250 new highly technical jobs   JSR Life Sciences, LLC announced that it is increasing its European footprint with…

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and…

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and…

Revolution in Healthcare | How robotics, virtual reality and artificial intelligence are improving the profession   Bilan, in partnership with…

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’…

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new…

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series…

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader…

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial…

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections  …

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series…

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by…

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of…

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients…

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial…

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad…

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial…

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article…

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial…

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article…

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is…

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was…

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series…

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The…

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by…

Marketing and distribution of a wide range of molecular controls and panels   The following article is part of BioAlps’…

How AI can support research by extracting, analysing and compiling data The following article is part of BioAlps’ testimonial series…

How AI applied to cough recordings can help in the identification of COVID-19 cases   The following article is part…

From spirit production to hand sanitisers   The following article is part of BioAlps’ testimonial series and was written by…

Adapting to become a satellite laboratory to carry out genetic testing of SARS-Cov-2 for the Fribourg Hospital (HFR)   The…

From exhaust gas cleaning system to easy-to-assemble face shield against COVID-19   The following article is part of BioAlps’ testimonial…

E4S’ Testimonial | A policy approach to fighting COVID-19   The following article is part of BioAlps’ testimonial series and…

A rapid sepsis test, the key to saving lives   The following article is part of BioAlps’ testimonial series and…

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by…

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’…

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’…

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by…

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA…

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the…

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new…

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and…

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based…

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics…

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a…

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University…

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories,…

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL…

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL…

Bachem supplies key anaesthetic drug to support fight against COVID-19   The Swiss-based company, Bachem, is the world leader in…

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take…

Abionic’s sepsis test supports the fight against COVID-19   When the pandemic hit, Abionic was finalising a financing round to…

Lonza | A key player in the COVID-19 vaccine production   Lonza, the Valais-based company, has signed a 10 year…

SNF NRP78 « Covid-19 » Call | Collaboration opportunity with SILAB   SILAB can be a real asset to develop…

ADC Therapeutics chooses the New York Stock Exchange   On 15 May 2020, the Biopôle-based company, ADC Therapeutics went public….

AquaNetto enables you to wear the same mask for an extended period of time   Based in the canton of…

Partners are taking Jakafi drug into a second late-stage trial for COVID-19 patients on ventilators   On 5 May 2020,…

In light of the COVID-19 situation, we are exceptionally posting information in French on our website. Do not hesitate to…

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP…

Avenue de Sécheron, 15

Medtronic is publicly sharing design specifications for its ventilators to support the fight against COVID-19   Medtronic is sharing the…

Adamant Innotech and CSEM develop a simultaneous diagnostic test for past COVID-19, flu and SRAS infections   On 9 April…